$CGON insider trading

Over the last 12 months, CG Oncology insiders reported 1 buy totaling $24.8M and 6 sales totaling $2.7M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.

$24.8M
$2.7M
7
3
100%
Side
$10K$100K$1.0M$10M$100MJun '26JulAug
POST LEONARD E
Mulay James
Liu Brian Guan-Chyun

All insider trades

Jul 15, 2026POST LEONARD E▼ Sale1,000$71.17$71K-100%
Jul 10, 2026Mulay James▼ Sale24,165$75.16$1.8M-100%
Jun 25, 2026Liu Brian Guan-Chyun▲ Buy371,085$66.87$24.8M+24.5%
Jun 24, 2026POST LEONARD E▼ Sale5,000$70$350K-100%
Jun 22, 2026POST LEONARD E▼ Sale5,000$65$325K-100%
Jun 15, 2026Mulay James▼ Sale1,964$60.12$118K-100%
Jun 4, 2026POST LEONARD E▼ Sale1,000$54.5$55K-100%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CGON feed.

CGON Insider Trading — Form 4 Buys & Sells | alphai